Neuroendocrine neoplasms of the gut and pancreas: new insights.
about
Laparoscopic versus open distal pancreatectomy for pancreatic cancerLaparoscopic versus open distal pancreatectomy for pancreatic cancerNeuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewCurrent state of knowledge on neuroendocrine small bowel tumours: non-systematic review of the literature based on one caseAltered MENIN expression disrupts the MAFA differentiation pathway in insulinomaSmall cell type neuroendocrine carcinoma colliding with squamous cell carcinoma at esophagus.Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based studyValue of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors.Loss of 11p11 is a frequent and early event in sporadic nonfunctioning pancreatic neuroendocrine neoplasms.Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomasKRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumorsGlobal microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysisMolecular pathology of pancreatic neuroendocrine tumors.Lymph nodes and survival in pancreatic neuroendocrine tumors.Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature.Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature reviewIdentification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors.Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parametersGenetic polymorphisms of interleukin 1β gene and sporadic pancreatic neuroendocrine tumors susceptibility.A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic CharacteristicsPancreatic neuroendocrine tumors: biology, diagnosis,and treatmentClinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.Autoimmune gastritis: histology phenotype and OLGA staging.The role of cell lines in the study of neuroendocrine tumors.Advancements in pancreatic neuroendocrine tumors.Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations.Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase.A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010-2012.Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas.Clinical presentation in insulinoma predicts histopathological tumour characteristics.
P2860
Q24185926-525067AC-EA64-4020-A98B-D6DE94291AA5Q24188242-A3D46C91-3B9C-46A2-9FB4-77845858D02CQ26768483-44526D77-6359-411C-B7B6-66A9C7473400Q26865730-02AD7DAE-0DE4-43BA-8CE1-23C478991E3EQ28577962-571B8653-1B35-4140-A3BA-0DEF808880C0Q33583104-3C67F940-1DA4-4844-9928-681BA76451CAQ33708663-CDC0E37F-21A4-4D86-9CD3-BAA243A3589EQ33743715-55C7E414-7925-4FB1-A2A7-7D2323A8626DQ33751294-38C3BD23-13F0-45EA-A406-906A24823DF9Q34000638-D7314289-8E0B-47FA-A77D-78C205F97571Q34036884-12CA8ECA-F638-4DCF-8398-A980A575B769Q34157801-1EB0FA0F-DA43-4651-B63D-616E1E08C333Q34553261-0EEB758C-3324-4320-8E12-883545E525ABQ35934630-0DD16399-4BC6-4E3D-AA3D-91EADCCFDEEFQ36162528-93C966AB-E2F3-4220-99C2-A478C978AFE5Q36250472-BE1FDB8E-D64F-43C2-8837-59B1E42BBD79Q36475761-97DCF9B7-5636-4E44-9A86-79A893A40ACFQ36705897-CC4BF77B-7345-45FA-A988-A15B25B04AD7Q36831577-EC46926E-2A80-428F-B7FF-8F27CDE5E7AFQ36983412-A198FC4C-5EF7-457B-95AE-6AACB481B56CQ37008655-552B33FA-0B80-4599-8FB4-71533181598DQ37097257-CF21FF23-C47A-4F67-8612-9112D421B263Q37354131-02220C45-F6AE-48B0-97A8-DDBCC8E14B04Q37624511-1271DD1F-0078-43D9-A10B-7C7515611EA0Q37698673-DCF490E7-B797-44B1-AE61-E92997ACE54EQ37981893-F3CF09F6-DA78-417E-B763-5BEB9AAFCCFDQ37985518-90A7C967-81E1-4C1A-A98F-53793C9AC1FDQ37986605-74F8D107-61BF-403A-9E5E-7FCD35354A01Q38004059-A7D24DF8-40BC-471C-B5A1-8FD2C2F64544Q38005913-256CCDA1-A87F-437A-9D2D-91205136568FQ38125257-E720D451-9D9C-488F-9649-2F3453CA5BD1Q38190817-268AC472-ACE1-4352-B2FF-4B36404A9186Q38202029-441A6E2E-A611-4DE4-905A-11D3A1C3893BQ38250467-0C8CB403-6F17-4776-B091-A0123F72DDA5Q38290097-78D93669-3A24-4D8C-BED7-7718DA474477Q38378928-B0B59784-C6F2-481A-B116-F2C543661C88Q38856277-B119CFBF-8473-44F2-9AF5-A8B849D3D751Q38996135-D07FEAAB-B255-470B-B3C0-CE92917E6337Q39256764-0F2C8809-C2A3-42D1-9C94-2944ACD549FBQ41148371-37CE9662-9280-4521-AFA7-B5473C790C34
P2860
Neuroendocrine neoplasms of the gut and pancreas: new insights.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Neuroendocrine neoplasms of the gut and pancreas: new insights.
@en
Neuroendocrine neoplasms of the gut and pancreas: new insights.
@nl
type
label
Neuroendocrine neoplasms of the gut and pancreas: new insights.
@en
Neuroendocrine neoplasms of the gut and pancreas: new insights.
@nl
prefLabel
Neuroendocrine neoplasms of the gut and pancreas: new insights.
@en
Neuroendocrine neoplasms of the gut and pancreas: new insights.
@nl
P2860
P356
P1476
Neuroendocrine neoplasms of the gut and pancreas: new insights.
@en
P2860
P2888
P356
10.1038/NRENDO.2011.120
P577
2011-08-02T00:00:00Z